Company intelligence / Profile preview

Guangzhou Shijing Medical Software

Guangzhou, Guangdong, Chinadnb.com ↗

Ownership: Private
Development stage: Other

Overview

Guangzhou Shijing Medical Software develops and markets digital therapeutic software and devices for the treatment of strabismus and amblyopia. Their products are commercially available and used in clinical settings such as hospitals and ophthalmic clinics. The company appears as a key player in global market reports for strabismus and amblyopia digital therapeutics.

Therapeutic areas: Ophthalmology
Modalities: DeviceSoftware (specifically digital therapeutics for ophthalmology)
Industry: Digital Health Medical Devices

Partnerships

Not specified; participates alongside other major players like Luminopia and NovaSight in industry reports.

Beyond the preview

Go deeper on Guangzhou Shijing Medical Software.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Shijing Medical Software.

Explore the full profile